The Mid-Norway Sepsis Research Group has 15 employees and conducts research, education and training to reduce sepsis incidence and mortality. The Centre has been developed through close collaboration between St. Olavs Hospital, Nord-Trøndelag Hospital Trust, NTNU and Yale University in the USA. We also receive funding from the Liaison Committee between the Central Norway Regional Health Authority and NTNU as well as the National Institutes of Health (NIH) in the USA. 

The foundation was laid by Arne Mehl, Senior Consultant in Infectious Diseases. He started registering clinical information for patients with bloodstream infections (BSIs) and sepsis who had bacteria in their blood at Levanger Hospital in Nord-Trøndelag in 1994, and at Namsos Hospital in 1999. In addition, the bacteria were registered and frozen. This has developed into a large clinical quality registry (the BSI registry) with almost 5000 registered cases of sepsis. Specialists in intensive medicine, infectious diseases, microbiology, epidemiology and genetics are now doing further work on this material and many other projects on sepsis. Doctors, nurses and engineers are linked with MNSS.